tiprankstipranks
Advertisement
Advertisement
Regeneron announces Health Canada approval of new indication for Libtayo
PremiumThe FlyRegeneron announces Health Canada approval of new indication for Libtayo
22d ago
Regeneron price target raised to $1,030 from $1,000 at Guggenheim
Premium
The Fly
Regeneron price target raised to $1,030 from $1,000 at Guggenheim
25d ago
Regeneron price target raised to $740 from $700 at Citi
Premium
The Fly
Regeneron price target raised to $740 from $700 at Citi
25d ago
Regeneron price target raised to $761 from $742 at Baird
PremiumThe FlyRegeneron price target raised to $761 from $742 at Baird
28d ago
Regeneron price target raised to $750 from $700 at Wells Fargo
Premium
The Fly
Regeneron price target raised to $750 from $700 at Wells Fargo
28d ago
Regeneron: Strong Execution, Growth Visibility and Pipeline Catalysts Drive Price Target Increase to $891
Premium
Ratings
Regeneron: Strong Execution, Growth Visibility and Pipeline Catalysts Drive Price Target Increase to $891
28d ago
Regeneron price target raised to $1,000 from $995 at Guggenheim
PremiumThe FlyRegeneron price target raised to $1,000 from $995 at Guggenheim
1M ago
Biohaven enters into clinical supply agreement with Regeneron
Premium
The Fly
Biohaven enters into clinical supply agreement with Regeneron
1M ago
Regeneron’s dupilumab granted orphan drug designation
Premium
The Fly
Regeneron’s dupilumab granted orphan drug designation
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100